HBW Insight is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Eileen Francis

Reporter – US

Eileen Francis is a reporter for “The Tan Sheet,” where she follows news on OTC drug and nutritional product manufacturing, regulation, legislation, finance and research. She previously served as a reporter and editor of “The Rose Sheet,” IBI’s source for in-depth coverage of the cosmetics industry. Early in her career, Eileen worked in public relations and as a writer for a lobbying firm. Outside of IBI, her freelance work includes articles on business, art and travel.

Latest From Eileen Francis

J&J’s Discontinuation Of Johnson’s Baby Powder Linked To April Federal Court Ruling

Legal experts note that J&J’s decision to end Johnson’s Baby Powder sales in the US and Canada closely followed a New Jersey federal court decision that largely denied the firm’s motions to bar testimony from plaintiff experts in multi-district talc litigation comprising around 16,000 cases.

United States Legal Issues

Vitamin D No ‘Magic Bullet’ Against COVID-19, But Should Be Part Of Nutrition Arsenal

Researchers say “no strong” evidence shows high vitamin D intake is beneficial to preventing or treating COVID-19, but adequate levels are needed to support immunity. Other researchers say countries should increase recommended vitamin D levels with “very suggestive” evidence supporting its effect against COVID-19 severity.

Dietary Supplements Coronavirus COVID-19

US Omega-3 Sales Expected To Grow Nearly 6% As Less ‘Mature’ Markets Accelerate

US and Europe led in 2019 sales of omega-3-fortified products worldwide, a market valued at $44bn that has extended beyond supplements and baby formulas to include foods, beverages and pet food, says GOED in report released 26 May. As the US market is ‘mature,’ its sales growth is expected at 5.8% in 2021, while sales of less mature markets such as Asia (excluding China) is anticipated to climb 12.6%.

Market Intelligence Dietary Supplements

GSK Appeals Industry Self-Regulation Forum’s Finding Against Benefiber ‘100% Natural’ Claim

GSK will appeal a finding that it doesn’t support its “100% Natural” claim for Benefiber Original and Healthy Shape. Question asked in the review from a P&G challenge reflects FDA’s ongoing consideration of whether a public health concern will emerge if it doesn’t substantially expand its regulation of use of the term.

Dietary Supplements Ad Complaints

GSK Enters Race For OTC COVID-19 Test With Mammoth Biosciences As Partner

GSK partners with biotech firm Mammoth Biosciences to develop a home-use OTC nasal swab test for COVID-19 that works in less than 20 minutes. Mammoth says the firms will seek an FDA emergency use authorization for the test, roll it out first to clinics and will seek approval for OTC sales. 

FDA OTC Devices

Zing Patch, Nubrain Water, Stay Alert Gummy: Alternatives To Caffeine In Energy Booster Space

Thync Global’s Zing Energy neurostimulation patch and Tesla Nootropics’ Nubrain Brainstorm caffeine-free water are promoted as alternatives to caffeine and energy drinks. They join a market dominated by big brands but with competition growing from products that boost energy without caffeine and sugar.

Launches Dietary Supplements
See All
UsernamePublicRestriction

Register